Musculoskeletal problems

Author(s):  
Chantal Simon ◽  
Hazel Everitt ◽  
Françoise van Dorp ◽  
Matt Burkes

Symptoms of musculoskeletal disease Neck pain Low back pain Shoulder problems Elbow problems Wrist and hand problems Hip and pelvis problems Knee problems Ankle and foot problems Sports medicine Management of sporting injuries Bone disorders Rickets and osteomalacia Osteoporosis Treatment options for osteoporosis Osteoarthritis Rheumatoid arthritis...

Author(s):  
Chantal Simon ◽  
Hazel Everitt ◽  
Françoise van Dorp ◽  
Nazia Hussain ◽  
Emma Nash ◽  
...  

This chapter in the Oxford Handbook of General Practice explores musculoskeletal problems encountered in general practice. It covers symptoms of musculoskeletal disease, neck and low back pain, and problems with the shoulder, elbow, wrist, hand, hip, knee, ankle, and foot. It explores sports medicine and the management of sporting injuries. It examines bone disorders, rickets, osteomalacia, osteoporosis, osteoarthritis, rheumatoid arthritis, spondyloarthropathies, and crystal-induced arthritis. It also discusses connective tissue disease, polymyalgia and giant cell arteritis, tiredness, and chronic fatigue syndrome.


BMC Medicine ◽  
2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Dongze Wu ◽  
Priscilla Wong ◽  
Cui Guo ◽  
Lai-Shan Tam ◽  
Jieruo Gu

Abstract Background With increasing life expectancy in China, no large population-based studies have been done on the trend for musculoskeletal disorders in China. We have investigated the pattern and trend of five major musculoskeletal disorders in China from the Global Burden of Disease Study 2017 and its association with sociodemographic index (SDI). Methods The main outcome measures were incidence, prevalence, and disability-adjusted life years (DALYs) for rheumatoid arthritis, osteoarthritis, low back pain, neck pain, and gout. Average annual percent change (AAPC) and annual percent change (APC) between 1990 and 2017 were analyzed with Joinpoint regression. Results The age-standardized rate of incidence, prevalence, and DALYs for the five major musculoskeletal disorders increased with age. For SDI, the age-standardized rate of DALYs was zigzagged increasing for rheumatoid arthritis and curvilinear increasing for gout, curvilinear decreasing for low back pain, and reaching to the highest point for osteoarthritis and neck pain with an SDI value of 0.61. The AAPC in age-standardized rate of DALYs indicated an increasing trend for rheumatoid arthritis (0.20, 95% CI 0.07, 0.34), osteoarthritis (0.26, 95% CI 0.20, 0.31), neck pain (0.09, 95% CI 0.07, 0.12), and gout (0.25, 95% CI 0.23, 0.27), but a decreasing trend for low back pain (− 0.96, 95% CI − 0.98, − 0.93). The AAPC of risk factors indicated a decreasing trend in smoking (− 0.14, 95% CI − 0.24, − 0.04) for rheumatoid arthritis, smoking (− 0.22, 95% CI − 0.24, − 0.19) and occupational ergonomic factors (− 1.25, 95% CI − 1.29, − 1.21) for low back pain, and impaired kidney function (− 0.95, 95% CI − 1.00, − 0.90) for gout, but an increasing trend in high body-mass index for osteoarthritis (3.10, 95% CI 3.03, 3.17), low back pain (3.07, 95% CI 2.99, 3.14), and gout (3.12, 95% CI 3.04, 3.20). Comparing the burden of five musculoskeletal diseases in China with the 19 countries of G20, China ranked first to second in the number of DALYs, and 12th to 16th in age-standardized rate of DALYs. Conclusion There are remarkably complex temporal patterns in disease burden and risk factors for five major musculoskeletal disorders across past three decades. Population-wide initiatives targeting high body-mass index may mitigate the burden of musculoskeletal disorders.


Work & Stress ◽  
1996 ◽  
Vol 10 (4) ◽  
pp. 322-335 ◽  
Author(s):  
H. Heuer ◽  
F. Klimmer ◽  
H. Kylian ◽  
A. Seeber ◽  
K. H. Schmidt ◽  
...  

2002 ◽  
Vol 95 (6) ◽  
pp. 642-646 ◽  
Author(s):  
MATHEW W. LIVELY

2021 ◽  
Author(s):  
Jafar Yahyavi Dizaj ◽  
Manijeh Soleimanifar ◽  
Reza Hashempour ◽  
Ali Kazemi Karyani ◽  
Fateh Mohsen ◽  
...  

Abstract Background: MSK health is imperative for the active participation of an individual in society and MSK related disorders more direly affects a person's quality of life compared other non-communicable disease while it also negatively effects the health system and economy of a country. The current manuscript analyzed and describes the disease burden of MSK disorders in the EMRO region.Methods: This was a cross-sectional descriptive-analytical study conducted based on data published by the Global Burden of Disease Database for MSK disorders up to 2017. The study target comprised population from all countries of the EMRO region of World Health Organization. The present study considered, MSK disorders such as (rheumatoid arthritis), (osteoarthritis), (Low back pain), (neck pain), (gout) and (other Musculoskeletal disorders. The DALY index was used to measure total disease burden.Results: MSK disorders in the world and in the EMRO region was ranked 5th (4% of total disease burden) and 7th (5% of total disease burden) among all diseases in 2017, respectively. Women over 30 years of age in the EMRO region had the highest risk of MSK disorders compared to other regions and in addition, the DALY lost in EMRO region due to MSK disorders was higher in women of all age categories than men. According to the results of this study, Low back pain, Other musculoskeletal disorders and Neck pain had the highest prevalence and burden of disease in the EMRO region and the world. Bahrain, Iran, and Morocco had the highest incidence of MSK DALY score in the EMRO region, and Somalia, Djibouti, and Afghanistan had the lowest incidence of MSK disorders and DALY score, respectively.Conclusion: With the increase in geriatric population and obesity especially in developing countries, consequently, more people tend to suffer from MSK disorders and it is predicted that this spike will continue in the coming decades. Taking in to account the high prevalence and burden of MSK disorders, forces government and health-policy makers to focus more on preventive cares and rehabilitation.


2021 ◽  
Author(s):  
Tomomi Anan ◽  
Shigeyuki Kajiki ◽  
Hiroyuki Oka ◽  
Tomoko Fujii ◽  
Kayo Kawamata ◽  
...  

BACKGROUND Musculoskeletal symptoms, such as neck and shoulder pain and stiffness and low back pain, are common health problems in the working population. They are the leading causes of presenteeism (employees being physically present at work but unable to be fully engaged). However, current medical systems do not spare sufficient resources for non-specific musculoskeletal problems. OBJECTIVE This study aimed to evaluate the improvements in musculoskeletal symptoms after use of an exercise-based artificial intelligence (AI)-assisted interactive health promotion system that operates through a mobile messaging app (the AI-assisted health program). METHODS We conducted a two-armed, randomized, controlled, and unblinded trial in workers with neck/shoulder stiffness and/or low back pain. We recruited participants with these symptoms through email notifications. We obtained 48 participants in the intervention group and 46 in the control group. The intervention group received the AI-assisted health program, in which the chatbot sent messages to users with the exercise instructions at a fixed time every day through the smart phone’s chatting app (LINE) for 12 weeks. The exercises could be performed within 1 minute. The control group continued with their usual care routines, which included exercising for 3 minutes at recess time provided by the company to prevent stiff shoulders and back pain. We assessed the subjective severities of the neck and shoulder pain/stiffness and low back pain in participants using a scoring scale of 1 to 5 for both the intervention and the control group at baseline and after 12 weeks of intervention using an online form. RESULTS We analyzed 47 patients in the intervention group and 40 in the control group. The participants in the intervention group showed significant improvements in the severities of the neck/shoulder pain/stiffness and low back pain compared to those in the control group (OR 12.74, P <.001). Based on the subjective assessment of the improvement of the pain/stiffness at 12 weeks, 36 (77%) participants in the intervention group and 3 (8%) in the control group had improved (improved, slightly improved) (OR 54.23, P <.001). CONCLUSIONS This study showed that the short exercises provided by the AI-assisted health program improved both neck/shoulder pain/stiffness and low back pain in 12 weeks. Digital health programs are low cost and safe and can save experts’ working hours and labor costs. Further studies are needed to identify the elements of the AI-assisted health program that worked. CLINICALTRIAL University hospital Medical Information Network-Clinical Trials Registry (UMIN-CTR) 000033894; https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038307.


2021 ◽  
Vol 41 (06) ◽  
pp. 760-770
Author(s):  
Rafid Mustafa ◽  
Narayan R. Kissoon

AbstractLow back pain and neck pain, often with associated radiculopathy, are two of the most common reasons for referral to the outpatient neurology clinic. A thorough clinical evaluation remains paramount in establishing an accurate diagnosis and subsequently an appropriate treatment plan. In this article, we review anatomic considerations for spondylotic radiculopathy; outline the clinical approach for the evaluation of these patients, including discussion of electrodiagnostic and imaging modalities; and address treatment options based on a stratified treatment approach.


2020 ◽  
pp. bjsports-2019-100886eoc1

Editorial NoteAs discussed in a recent editorial, the British Journal of Sports Medicine (BJSM) rescinds the Expression of Concern [1] for a recent network meta-analysis (NMA) [2] that was issued solely on the basis of comments by Professor Maher and colleagues [3]. The original authors (Dr Belavy and colleagues) have responded [4]. The original NMA paper did not require any changes. We editors of the BJSM have full confidence in the findings of the NMA [2]. The findings of the NMA inform clinical practice and can serve to inform clinical practice guidelines.Karim Khan, MD, PhDEditor-in-Chief, BJSMJuly 27th, 2020REFERENCES1 Expression of concern: Which specific modes of exercise training are most effective for treating low back pain? Network meta-analysis. Br J Sports Med 2020;:bjsports-2019-100886eoc1. doi:10.1136/bjsports-2019-100886eoc12 Owen PJ, Miller CT, Mundell NL, et al. Which specific modes of exercise training are most effective for treating low back pain? Network meta-analysis. Br J Sports Med 2019;:in press. doi:10.1136/bjsports-2019-1008863 Maher CG, Hayden JA, Saragiotto BT, et al. Letter in response to: “Which specific modes of exercise training are most effective for treating low back pain? Network meta-analysis” by Owen et al. Br J Sports Med Published Online First: 5 February 2020. doi:10.1136/bjsports-2019-1018124 Belavy DL, Owen PJ, Miller CT, et al. Response to Discussion: “Which specific modes of exercise training are most effective for treating low back pain? Network meta-analysis.” Br J Sports Med Published Online First: 10 June 2020. doi:10.1136/bjsports-2020-102673


2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Elisabeth Gjefsen ◽  
Lars Christian Haugli Bråten ◽  
Guro Løvik Goll ◽  
Monica Wigemyr ◽  
Nils Bolstad ◽  
...  

Abstract Background Low back pain is common and a significant number of patients experience chronic low back pain. Current treatment options offer small to moderate effects. Patients with vertebral bone marrow lesions visualized as Modic changes on magnetic resonance imaging may represent a subgroup within the low back pain population. There is evidence for inflammatory mediators being involved in development of Modic changes; hence, suppression of inflammation could be a treatment strategy for these patients. This study examines the effect of anti-inflammatory treatment with the TNF-α inhibitor infliximab in patients with chronic low back pain and Modic changes. Methods/design The BackToBasic trial is a multicenter, double blind, randomized controlled trial conducted at six hospitals in Norway, comparing intravenous infusions with infliximab with placebo. One hundred twenty-six patients aged 18–65 with chronic low back pain and type 1 Modic changes will be recruited from secondary care outpatients’ clinics. The primary outcome is back pain-specific disability at day 154 (5 months). The study is designed to detect a difference in change of 10 (SD 18) in the Oswestry Disability Index at day 154/ 5 months. The study also aims to refine MRI-assessment, investigate safety and cost-effectiveness and explore the underlying biological mechanisms of Modic changes. Discussion Finding treatments that target underlying mechanisms could pose new treatment options for patients with low back pain. Suppression of inflammation could be a treatment strategy for patients with low back pain and Modic changes. This paper presents the design of the BackToBasic study, where we will assess the effect of an anti-inflammatory treatment versus placebo in patients with chronic low back pain and type 1 Modic changes. The study is registered at ClinicalTrials.gov under the identifier NCT03704363. The EudraCT Number: 2017–004861-29.


Sign in / Sign up

Export Citation Format

Share Document